Company / AR per Share
Amgen AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$17.82
FY2025
5-year range
$8.46 / $17.82
FY2021-FY2025
Trend
+40.7%
vs FY2024
Sector context
#4 of 115
Health Care
What the data says
Among 115 Health Care companies, Amgen is in the top 3% for ar per share. Improved from $13.61 to $17.82 over the past 2 years.
Based on SEC 10-K filings.
17.82 in FY2025 with a 5-year CAGR of +18.4%. Top quartile in the Health Care sector.
Improved from $13.61 to $17.82 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +21.4%
- 5-Year CAGR
- +18.4%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 115This company $17.82 Sector average $27.09
▼
-34.2% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 40.7% year-over-year.
- Ranks #4 out of 115 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.82 | +40.7% |
| FY2024 | $12.67 | -6.9% |
| FY2023 | $13.61 | +36.6% |
| FY2022 | $9.96 | +17.7% |
| FY2021 | $8.46 | +10.6% |
| FY2020 | $7.65 | +18.7% |
| FY2019 | $6.44 | +30.0% |
| FY2018 | $4.96 | +13.0% |
| FY2017 | $4.38 | +4.5% |
| FY2016 | $4.20 | +6.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026